Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)

Bibliography

• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199-229
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms. Mol Divers 2011;15:305-16
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-89
   PubMed Web of Science ®Google Scholar
• Aggarwal M, McKenna R. Update on carbonic anhydrase inhibitors: a patent review (2008 – 2011). Expert Opin Ther Patents 2012;22:903-15
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Patents 2006;16:1627-64
   Web of Science ®Google Scholar
• Aggarwal M, Boone CD, Kondeti B, et al. Structural annotation of human carbonic anhydrases. J Enzyme Inhib Med Chem 2013;28:267-77
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms ? Chem Rev 2012;112:4421-68
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Minakuchi T, et al. Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition. Bioorg Med Chem Lett 2013;23:256-60
   PubMed Web of Science ®Google Scholar
• Lehtonen J, Shen B, Vihinen M, et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004;279:2719-27
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Patents 2000;10:575-600
   Web of Science ®Google Scholar
• Bootorabi F, Janis J, Hytonen VP, et al. Acetaldehyde-derived modifications on cytosolic human carbonic anhydrases. J Enzyme Inhib Med Chem 2011;26:862-70
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72
   PubMed Web of Science ®Google Scholar
• Maren TH. Carbonic anhydrase: chemistry, physiology and inhibition. Physiol Rev 1967;47:595-781
   PubMed Web of Science ®Google Scholar
• Liao SY, Ivanov S, Ivanova A, et al. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. J Med Genet 2003;40:257-61
   PubMed Web of Science ®Google Scholar
• Supuran CT, Parkkila S. Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms. WO139678; 2010
   Google Scholar
• Ebbesen P, Supuran CT, Scozzafava A, et al. Carbonic anhydrase inhibitors. WO098610; 2011
   Google Scholar
• Supuran C, Dedhar S, McDonald P, et al. Novel sulfonamide compounds for inhibition of metastatic tumor growth. WO021963; 2012
   Google Scholar
• Supuran C, Dedhar S, Carta F, et al. Carbonic anhydrase inhibitors with antimetastatic activity. WO070024; 2012
   Google Scholar
• Masereel B, Frederick R, Supuran CT. Tetraline sulfonamide derivatives for use in the treatment of proliferative disorders. WO175654; 2012
   Google Scholar
• Lonnerholm G, Wistrand PJ, Barany E. Carbonic anhydrases isoenzymes in the rat kidney. Effects of chronic acetazolamide treatment. Acta Physiol Scand 1986;126:51-60
   PubMedGoogle Scholar
• Hilvo M, Rafajova M, Pastorekova S, et al. Expression of carbonic anhydrase IX in mouse tissues. J Histochem Cytochem 2004;52:1313-22
   PubMedGoogle Scholar
• Kyllonen MS, Parkkila S, Rajaniemi H, et al. Localization of carbonic anhydrase XII to the basolateral membrane of H+-secreting cells of mouse and rat kidney. J Histochem Cytochem 2003;51:1217-24
   PubMedGoogle Scholar
• Kaunisto K, Parkkila S, Rajaniemi H, et al. Carbonic anhydrase XIV: luminal expression suggests key role in renal acidification. Kidney Int 2002;61:2111-18
   PubMed Web of Science ®Google Scholar
• Parkkila S, Parkkila AK, Kivela J. Role of carbonic anhydrase and its inhibitors in biological science related to gastroenterology, neurology and nephrology. In: Supuran CT, Scozzafava A, Conway J, editors. Carbonic anhydrase – its inhibitors and activators. CRC Press, Boca Raton (FL); 2004. p. 281-303
   Google Scholar
• Jackson EK. Diuretics. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 9th edition. McGraw-Hill, New York; 1996. p. 685-713
   Google Scholar
• Maren TH. Benzolamide. A renal carbonic anhydrase inhibitor. In: Karch FE, editor. Orphan drugs. Marcel Dekker, New York and Basel; 1982. p. 89-115
   Google Scholar
• Nawata CM, Hung CC, Tsui TK, et al. Ammonia excretion in rainbow trout (Oncorhynchus mykiss): evidence for Rh glycoprotein and H+-ATPase involvement. Physiol Genomics 2007;31:463-74
   PubMed Web of Science ®Google Scholar
• Weiner ID, Verlander JW. Renal and hepatic expression of the ammonium transporter proteins, Rh B Glycoprotein and Rh C Glycoprotein. Acta Physiol Scand 2003;179:331-8
   PubMedGoogle Scholar
• Lonnerholm G. Histochemical demonstration of carbonic anhydrase in the human kidney. Acta Physiol Scand 1973;88:455-69
   PubMedGoogle Scholar
• Lonnerholm G, Ridderstrale Y. Distribution of carbonic anhydrase in the frog nephron. Acta Physiol Scand 1974;90:764-78
   PubMedGoogle Scholar
• Lonnerholm G, Ridderstrale Y. Intracellular distribution of carbonic anhydrase in the rat kidney. Kidney Int 1980;17:162-74
   PubMed Web of Science ®Google Scholar
• Spicer SS, Ge ZH, Tashian RE, et al. Comparative distribution of carbonic anhydrase isozymes III and II in rodent tissues. Am J Anat 1990;187:55-64
   PubMedGoogle Scholar
• Sato A, Spicer SS. Cell specialization in collecting tubules of the guinea pig kidney: carbonic anhydrase activity and glycosaminoglycan production in different cells. Anat Rec 1982;202:431-43
   PubMedGoogle Scholar
• Schwartz GJ. Physiology and molecular biology of renal carbonic anhydrase. J Nephrol 2002;15:S61-74
   PubMedGoogle Scholar
• Sly WS, Hewett-Emmett D, Whyte MP, et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 1983;80:2752-6
   PubMed Web of Science ®Google Scholar
• Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Ann Rev Biochem 1995;64:375-401
   PubMed Web of Science ®Google Scholar
• Parkkila S, Rajaniemi H, Parkkila AK, et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000;97:2220-4
   PubMed Web of Science ®Google Scholar
• Pastorek J, Pastorekova S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88
   PubMed Web of Science ®Google Scholar
• Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767-77
   PubMed Web of Science ®Google Scholar
• Buanne P, Renzone G, Monteleone F, et al. Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells. J Proteome Res 2013;12:282-92
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233-45
   PubMed Web of Science ®Google Scholar
• Carta F, Scozzafava A, Supuran CT. Sulfonamides (RSO2NH2): a patent review 2008-2012. Expert Opin Ther Patents 2012;22:747-58
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Carta F, Supuran CT. Secondary and tertiary sulfonamides: a patent review (2008 – 2012). Expert Opin Ther Patents 2013;23:203-13
   PubMed Web of Science ®Google Scholar
• Carta F, Supuran CT, Scozzafava A. Novel therapies for glaucoma: a patent review 2007-2011. Expert Opin Ther Patents 2012;22:79-88
   PubMed Web of Science ®Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, et al. CA IX-specific inhibitors. US7829065; 2010
   Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, et al. CA IX-specific inhibitors. US7833734; 2010
   Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, et al. CA IX-specific inhibitors. US7833737; 2010
   Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, et al. CA IX-specific inhibitors. US7833738; 2010
   Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, et al. CA IX-specific inhibitors. US7833739; 2010
   Google Scholar
• Supuran C, Scozzafava A, Pastorekova S, et al. CA IX-specific inhibitors. US7833514; 2010
   Google Scholar
• Supuran CT, Scozzafava A, Pettersen EO, et al. Carbonic anhydrase isoform IX inhibitor coated gold nanoparticles and uses thereof. US6125898; 2009
   Google Scholar
• Supuran CT, Scozzafava A. Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as therapeutic and diagnostic agents. WO137092; 2006
   Google Scholar
• Supuran C, Benedini F, Biondi S, et al. Nitrate esters of carbonic anhydrase inhibitors. WO071421; 2008
   Google Scholar
• Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008;14:641-8
   PubMed Web of Science ®Google Scholar
• Temperini C, Cecchi A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited – old leads for new applications? Org Biomol Chem 2008;6:2499-506
   PubMed Web of Science ®Google Scholar
• Temperini C, Cecchi A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with twelve mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. Bioorg Med Chem Lett 2008;18:2567-73
   PubMed Web of Science ®Google Scholar
• Temperini C, Cecchi A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: when three water molecules and the keto-enol tautomerism make the difference. J Med Chem 2009;52:322-8
   PubMed Web of Science ®Google Scholar
• Temperini C, Cecchi A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Bioorg Med Chem 2009;17:1214-21
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor. J Enzyme Inhib Med Chem 2004;19:269-3
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin Ther Patents 2004;14:667-702
   Web of Science ®Google Scholar
• Wank R. Use of diuretics for treating swellings. US0234107; 2005
   Google Scholar
• Padilla MC, Armas-Hernandez MJ, Hernandez RH, et al. Update of diuretics in the treatment of hypertension. Am J Ther 2007;14:154-60
   PubMedGoogle Scholar
• Smith RE, Ashiya M. Antihypertensive therapies. Nat Rev Drug Discov 2007;6:597-8
   PubMed Web of Science ®Google Scholar
• Elliott WJ. Systemic hypertension. Curr Probl Cardiol 2007;32:201-59
   PubMed Web of Science ®Google Scholar
• Patel A; ADVANCE Collaborative GroupMacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40
   PubMed Web of Science ®Google Scholar
• Piecha G, Adamczak M, Chudek J, et al. Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. Kidney Blood Press Res 2007;30:187-94
   PubMed Web of Science ®Google Scholar
• Zannad F. Benefits of first line combination of perindopril and indapamide in clinical practice for patients with hypertension and diabetes. Am J Hepertension 2007;20:9S-14S
   Google Scholar
• Einhorn PT, Davis BR, Massie BM, et al. The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) heart failure validation study: diagnosis and prognosis. Am Heart J 2007;153:42-53
   PubMedGoogle Scholar
• Kharwade P, Bhushan I. Composition comprising beta-adrenergic receptor antagonists and diuretics. US0107726; 2008
   Google Scholar
• Sasmal BK, Reddy BP, Nasare VD, et al. Treatment and prevention of cardiovascular events. US0068269; 2010
   Google Scholar
• Hartley CE. Composition comprising a diuretic and a cardiac glycoside for the treatment of DNA viral infections of the eye. US0137232; 2010
   Google Scholar
• Straub M, Witte K, Ziegler D, et al. Pharamceutical compositions comprising NEP-inhibitors, inhiibtors of the endogenous endothelin producing system and diuretics. US0323012; 2010
   Google Scholar
• Winum JY, Maresca A, Carta F, et al. Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases. Chem Commun 2012;48:8177-9
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: off-targets, add-on activities, or emerging novel targets? In: Peters JU, editor. Polypharmacology in drug discovery. Wiley, Hoboken; 2012. p. 459-91
   Google Scholar
• Lee HS, Bae T, Lee JH, et al. Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Syst Biol 2012;6:80
   PubMed Web of Science ®Google Scholar
• Shirakura T, Tamura M, Takahashi Y, et al. Therapeutic drug for hypertension or prehypertension. US0046192; 2011
   Google Scholar
• Dill DA. Extended-release formultion for reducing the frequency of urination and method used thereof. US0135050; 2012
   Google Scholar
• Mathiowitz E, Laulicht B. Composition and methods for loop diuretics with consistent bioavailability. US0053156; 2012
   Google Scholar
• Feldman DL, Webb RL. Pharmaceutical composition comprising a renin inhibitor, calcium channel blocker and a diuretic. US0071470; 2012
   Google Scholar
• Hochman DW, Partdridge JJ. Diuretic and diuretic-like compound analogs. US0234721; 2012
   Google Scholar
• Taki K, Hirahara K, Tomita S, et al. Acetazolamide-induced increase in blood flow to rabbit organs is confirmed using colored microspheres. Heart Vessels 1998;13:63-7
   PubMed Web of Science ®Google Scholar
• Taki K, Kato H, Endo S, et al. Cascade of acetazolamide-induced vasodilatation. Res Commun Mol Pathol Pharmacol 1999;103:240-8
   PubMed Web of Science ®Google Scholar
• Taki K, Oogushi K, Hirahara K, et al. Preferential acetazolamide-induced vasodilation based on vessel size and organ: confirmation of peripheral vasodilation with use of colored microspheres. Angiology 2001;52:483-8
   PubMed Web of Science ®Google Scholar
• Okazawa H, Yamauchi H, Sugimoto K, et al. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001;21:1472-9
   PubMed Web of Science ®Google Scholar
• Pedersen DB, Koch Jensen P, la Cour M, et al. Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels. Graefes Arch Clin Exp Ophthalmol 2005;243:163-8
   PubMed Web of Science ®Google Scholar
• Horita Y, Yakabe K, Tadokoro M, et al. Renal circulatory effects of acetazolamide in patients with essential hypertension. Am J Hypertens 2006;19:282-5
   PubMed Web of Science ®Google Scholar
• Josefsson A, Sigurdsson SB, Bang K, et al. Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries. Exp Eye Res 2004;78:215-21
   PubMed Web of Science ®Google Scholar
• Chobanyan-Jurgens K, Schwarz A, Bohmer A, et al. Renal carbonic anhydrases are involved in the reabsorption of endogenous nitrite. Nitric Oxide 2012;26:126-31
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Mincione F, Somma T, et al. A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 2012;27:138-47
   PubMed Web of Science ®Google Scholar
• Nishioku T, Takata F, Yamauchi A, et al. Protective action of indapamide, a thiazide-like diuretic, on ischemia-induced injury and barrier dysfunction in mouse brain microvascular endothelial cells. J Pharmacol Sci 2007;103:323-7
   PubMedGoogle Scholar
• Struijker-Boudier HA. From macrocirculation to microcirculation: benefits of preterax. Am J Hepertension 2007;20:15S-8S
   Web of Science ®Google Scholar
• Iyer EK, Jha RKJ, Jain GK, et al. Cardiovascular combinations using renin-angiotensin inhibitors. WO010008; 2008
   Google Scholar
• Shetty SS. Combination of renin inhibitor and diuretics. WO077418; 2005
   Google Scholar
• Witte K, Ziegler D, Straub M, et al. Pharmaceutical compositions comprising Nep inhibitors, inhibitors of the endogenous endothelin producing system and diuretics. WO087371; 2006
   Google Scholar
• Radzik D, Van Eickels M. Combination of dronedarone with at least one diuretic, and therapeutic use thereof. US0136899; 2011
   Google Scholar
• Woo SH. Controlling body fluid condition using diuretics. WO029899; 2009
   Google Scholar
• Brendel E, Ohm A, Kuhl A, et al. Pharmaceutical dosage form comprising nifedipine or nisoldipine nd an angiotensin-II antagonist and/or a diuretic. MX005023; 2011
   Google Scholar
• Dillaha L, Schutter E. Alpha-2-adrenergic agonists and angiotensin II receptor antagonist composition. WO065489; 2010
   Google Scholar
• Talwar N, Sebastian D, Philip M. A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide. WO147026; 2011
   Google Scholar
• Sedmak G, Vrecer F. Multilyer pharmaceutical tablet comprising telmisartan and a diuretic. WO161123; 2012
   Google Scholar
• Miner J. Hypertension and hyperuircemia. WO162323; 2012
   Google Scholar
• Lolis E, Cho Y, Bucala R, et al. Compounds and methods for ACEMIF inhibition and the treatment of parasites. WO033878; 2012
   Google Scholar